Therefore, as a potent V-ATPase inhibitor, TSN may also be a promising drug candidate for the treatment of diseases with abnormally elevated cell acidity, including autoimmune diseases, osteoporosis, and cancers 58. The gene discussed is TSN; the disease is autoimmune disease.